Visensia 3.3 Released
OBS Medical are pleased to announce the release of Visensia 3.3. This is a new release with some enhancements. Users of previous releases are encouraged to upgrade. Please “read more” for the full details of the release.
News
OBS Medical Ltd Announces 510k Clearance for Visensia
OBS Medical Ltd, today announced that Visensia has received 510k clearance from the FDA. This is the fourth 510k clearance for Visensia since the original introduction of Visensia (Originally known as BioSignTM) in 2005. Visensia was the first FDA cleared patient health index device with alerts on the market and is continuing to develop innovative leading edge products.
OBS Medical’s BIOQT Recognized as Finalist for Prestigious “Healthcare IT Innovation Award”
OBS Medical’s BIOQT™ technology has been recognized as a top finalist for the prestigious TechPoint Mira Award “Healthcare IT Innovation Award”.
VivoMetrics’ Partners with OBS Medical to Develop Decision Assist Software for Remote Patient Monito
New dynamic health status index aims to improve patient safety and enhance outcomes by enabling telehealth providers to intervene earlier in patient care
OBS Medical’s Visensia patient monitoring technology lowers cost of medical malpractice insurance
OBS Medical has entered into an agreement with Beazley, a major Lloyd’s of London-based insurer of medical malpractice for US hospitals, for Beazley to provide insurance coverage at a reduced cost to hospitals that implement OBS’s Visensia® patient monitoring technology to provide early warning of clinical crises.
Grand Opening of Hauenstein Center Features Visensia’s Early Warning System for Patient Safety
Saint Mary’s Health Care, a member organization of Trinity Health, has completed its new Hauenstein Center facility and celebrated with several Grand Opening events, including a Community Open House on Sunday, February 15.
Frost & Sullivan Recognizes Excellence in Healthcare Innovation
Frost & Sullivan Commends OBS Medical’s Innovative Approach to Patient Monitoring
Based on its recent analysis of the central stations patient monitoring market, Frost & Sullivan recognizes OBS Medical with the 2008 North American Frost & Sullivan Technology Innovation Award for its cutting edge Visensia® Hospital Patient Safety Suite.
Visensia Summit for Patient Safety Brings Together Healthcare Leaders
OBS Medical hosted its first-ever Visensia® Summit on September 8. It welcomed key leaders in patient safety to its hometown of Indianapolis.
Michigan Hospital Selects Visensia® Automated Early Warning to Improve Hospital Patient Safety
OBS Medical announced today that a major Michigan-based hospital has selected Visensia Automated Early Warning technology to support its patient care operations.
OBS Medical Receives New FDA 510(k) Clearance Expanding Visensia Solutions for Hospital Patient Safe
OBS Medical announced today that the Food and Drug Administration has granted 510(k) clearance for the company to market its Visensia Alert in the United States.
OBS Medical’s Visensia validated as effective patient safety solution in “Archives of Internal Medic
OBS Medical’s predictive patient safety technology, Visensia®, was the focus of a large study and peer-reviewed paper that was published in the June 23rd issue of Archives of Internal Medicine, published by the American Medical Association.
OBS Medical’s Visensia® Validated as Valuable Rapid Response Trigger at International Symposium
At the 4th International Symposium on Rapid Response Systems and Medical Emergency Teams, Title Sponsor OBS Medical featured its expanded Visensia® predictive technology to improve patient safety throughout the hospital.